InvestorsHub Logo
Followers 117
Posts 19094
Boards Moderated 0
Alias Born 08/27/2005

Re: no2koolaid post# 248711

Friday, 03/31/2017 4:22:21 PM

Friday, March 31, 2017 4:22:21 PM

Post# of 402406
It is amazing how companies that have absolutely no revenues and only their PIP get valued at such a high price. It has already been
brought to light that if Elite were strictly an R&D company with no
products generating revenues with which to sustain itself that Elite might be valued differently...... as in much higher a price per share. As I recall both Jerry and Nasrat had brought this up at times.

The market is what it is.... fickle.

SequestOx once approved is highly likely to be a dominant formulation given the circumstances of the current prescription
opioid abuse situation country wide.

Unless there is a way to safeguard current prescription opioids such that only the patient can take them it does not matter who prescribes them or fills the prescription. The abuse will continue
and only get worse. Pharmaceutical companies that manufacture these
drugs know this.... furthermore they don't care about the collateral damage. Only thing these companies care about is money
made from the sale of these drugs.

As for the magical way in which only the patient can have access to pills without some technological highly expensive safeguard....
there is none. Probable that there never ever will be any such solution.

Best solution to date is the technology Elite has. Once pill poppers figure out that they can't get that rush off of SequestOx
they will have to find some other means..... maybe go back to
non pharmaceutical grade heroin.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News